← Back to Search
Chitosan: A Promising Therapeutic Agent And Effective Drug Delivery System In Managing Diabetes Mellitus.
S. Sarkar, D. Das, Prachurjya Dutta, Jatin Kalita, S. B. Wann, P. Manna
Published 2020 · Medicine
Download PDFAnalyze on Scholarcy
Chitosan, a promising carbohydrate biopolymer is gaining scientific attention in a wide range of biomedical applications due to its outstanding chemical and pharmacokinetic properties. Recently, various studies have demonstrated the beneficial activities of chitosan in protecting and proliferating pancreatic beta cells, lowering hyperglycemia, and preventing impaired lipid metabolism associated diabetes mellitus. Moreover, chitosan has also been used in formulating several types of micro/nano-carriers for the delivery of different antidiabetic drugs, like insulin, GLP1, exendin-4, DPP-4 inhibitor, and plasmid encoding insulin or GLP to reduce hyperglycemia. This review for the first time provides an overview of the currently available evidences on the potential benefits of chitosan in managing diabetes mellitus and also emphasizes on the chitosan-based micro/nano-carriers in delivery of various antidiabetic drugs via oral, nasal, and subcutaneous routes. The outcome of this review will be helpful for the development of a novel therapeutic to achieve better control of diabetes mellitus.
This paper references
Diabetes and lipid metabolism
V. Athyros (2018)
Oral delivery of an anti-diabetic peptide drug via conjugation and complexation with low molecular weight chitosan.
Sukyung Ahn (2013)
Self-assembly pH-sensitive chitosan/alginate coated polyelectrolyte complexes for oral delivery of insulin
T. Chen (2019)
Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: Oral delivery using pH-responsive nanoparticles vs. subcutaneous injection.
K. Sonaje (2010)
A smart pH-responsive nano-carrier as a drug delivery system for the targeted delivery of ursolic acid: suppresses cancer growth and metastasis by modulating P53/MMP-9/PTEN/CD44 mediated multiple signaling pathways.
K. Jiang (2017)
Nanoencapsulated chitosan nanoparticles in emulsion-based oral delivery system: In vitro and in vivo evaluation of insulin loaded formulation
Gülşah Erel (2016)
Preservation of β-cell function: the key to diabetes prevention.
R. DeFronzo (2011)
Corrigendum: Combinatorial nanocarrier based drug delivery approach for amalgamation of anti-tumor agents in breast cancer cells: an improved nanomedicine strategy
C. Murugan (2016)
Chitin and Chitosan: Structure, Properties and Applications in Biomedical Engineering
S. M. A. Islam (2016)
Functional Comparison of High and Low Molecular Weight Chitosan on Lipid Metabolism and Signals in High-Fat Diet-Fed Rats
S. Liu (2018)
Why is chitosan mucoadhesive?
Ioannis A Sogias (2008)
Alginate/Chitosan Nanoparticles are Effective for Oral Insulin Delivery
B. Sarmento (2007)
Chitosan oligosaccharide (GO2KA1) improves postprandial glycemic response in subjects with impaired glucose tolerance and impaired fasting glucose and in healthy subjects: a crossover, randomized controlled trial
S. Jeong (2019)
Transdermal Delivery of Insulin by Amidated Pectin Hydrogel Matrix Patch in Streptozotocin-Induced Diabetic Rats: Effects on Some Selected Metabolic Parameters
S. I. Hadebe (2014)
AMP-activated protein kinase regulates PEPCK gene expression by direct phosphorylation of a novel zinc finger transcription factor.
E. Inoue (2006)
Chitosans as Absorption Enhancers for Poorly Absorbable Drugs. 1: Influence of Molecular Weight and Degree of Acetylation on Drug Transport Across Human Intestinal Epithelial (Caco-2) Cells
N. G. Schipper (2004)
Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).
G. Wang (2016)
Chitosan and the mucosal delivery of biotechnology drugs.
Mohamed M. Issa (2005)
Involvement of protein kinase C in chitosan glutamate-mediated tight junction disruption.
J. Smith (2005)
Cellular uptake and transport characteristics of chitosan modified nanoparticles in Caco-2 cell monolayers.
T. Dou (2019)
Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release
W. Garvey (2014)
Adiponectin represses gluconeogenesis independent of insulin in hepatocytes.
H. Zhou (2005)
Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2).
A. Kotzé (1998)
Multistage pH-responsive mucoadhesive nanocarriers prepared by aerosol flow reactor technology: A controlled dual protein-drug delivery system.
N. Shrestha (2015)
Biodegradable Triblock Copolymer Microspheres Based on Thermosensitive Sol-Gel Transition
Y. M. Kwon (2004)
Recent advances on chitosan-based micro- and nanoparticles in drug delivery.
S. Agnihotri (2004)
Antidiabetic effect and mechanism of chitooligosaccharides.
C. Ju (2010)
In vitro and in vivo evaluation of thermosensitive chitosan hydrogel for sustained release of insulin
Farzaneh Ghasemi Tahrir (2016)
Toxicological, medical and industrial hygiene aspects of glutaraldehyde with particular reference to its biocidal use in cold sterilization procedures
B. Ballantyne (2001)
Effects of interpenetration of thermo-sensitive gels by crosslinking of chitosan on nasal delivery of insulin: In vitro characterization and in vivo study
T. W. Chung (2010)
A study of insulin-chitosan complex nanoparticles used for oral administration
F. Cui (2004)
Effect of Dietary Chitosans with Different Viscosity on Plasma Lipids and Lipid Peroxidation in Rats Fed on A Diet Enriched with Cholesterol
M. Chiang (2000)
Cp1-11 peptide/insulin complex loaded pH-responsive nanoparticles with enhanced oral bioactivity.
Xingyu Chen (2019)
Intracellular trafficking and decondensation kinetics of chitosan-pDNA polyplexes.
M. Thibault (2010)
Poly(alkyl cyanoacrylate) nanospheres for oral administration of insulin.
C. Damgé (1997)
Current challenges in non-invasive insulin delivery systems: a comparative review.
E. Khafagy (2007)
Nasal delivery of insulin using chitosan microspheres
J. Varshosaz (2004)
Chitosans as Absorption Enhancers for Poorly Absorbable Drugs 2: Mechanism of Absorption Enhancement
N. G. Schipper (2004)
“The Good, the Bad and the Ugly” of Chitosans
B. Bellich (2016)
An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery
M. Mohammed (2017)
Chitosan-based gastrointestinal delivery systems.
Radi Hejazi (2003)
Effective and safe gene-based delivery of GLP-1 using chitosan/plasmid-DNA therapeutic nanocomplexes in an animal model of type 2 diabetes
M. Jean (2011)
Interaction of bile acids, phospholipids, cholesterol and triglyceride with dietary fibers in the small intestine of rats.
K. Ebihara (1989)
Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery.
Yu-Hsin Lin (2007)
Effect of long-term supplementation of low molecular weight chitosan oligosaccharide (GO2KA1) on fasting blood glucose and HbA1c in db/db mice model and elucidation of mechanism of action
Jong-Gwan Kim (2014)
New insights into chitosan-DNA interactions using isothermal titration microcalorimetry.
P. Ma (2009)
Nasal Delivery of Insulin Using Novel Chitosan Based Formulations: A Comparative Study in Two Animal Models Between Simple Chitosan Formulations and Chitosan Nanoparticles
A. Dyer (2004)
Chitosan-Based Nanomaterials for Drug Delivery
Jianghua Li (2018)
Continuous and massive intake of chitosan affects mineral and fat-soluble vitamin status in rats fed on a high-fat diet.
K. Deuchi (1995)
Chitosan-zinc-insulin complex incorporated thermosensitive polymer for controlled delivery of basal insulin in vivo.
M. Oak (2012)
N‐trimethyl chitosan nanoparticles and CSKSSDYQC peptide: N‐trimethyl chitosan conjugates enhance the oral bioavailability of gemcitabine to treat breast cancer
Guanyu Chen (2018)
Chitooligosaccharide Biguanide Repairs Islet β‐Cell Dysfunction by Activating the IRS‐2/PI3K/Akt Signaling Pathway in Type 2 Diabetic Rats
Yalu Zou (2019)
Oral insulin delivery by self-assembled chitosan nanoparticles: in vitro and in vivo studies in diabetic animal model.
Piyasi Mukhopadhyay (2013)
Antidiabetic activity of nanopowdered chitosan in db/db mice
M. H. Seo (2010)
Diabetic Dyslipidemia: Basic Mechanisms Underlying the Common Hypertriglyceridemia and Low HDL Cholesterol Levels
H. Ginsberg (1996)
Nasal Delivery of Insulin Using Bioadhesive Chitosan Gels
J. Varshosaz (2006)
Managing diabetes with nanomedicine: challenges and opportunities
O. Veiseh (2015)
Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors.
C. Lee (2003)
Production, Properties, and Some New Applications of Chitin and Its Derivatives
J. Synowiecki (2003)
Scalable fabrication of size-controlled chitosan nanoparticles for oral delivery of insulin.
Zhiyu He (2017)
Chitosans for enhanced delivery of therapeutic peptides across intestinal epithelia: in vitro evaluation in Caco-2 cell monolayers
A. Kotzé (1997)
Chitosan: some pharmaceutical and biological aspects ‐ an update
A. K. Singla (2001)
Enhanced oral absorption of insulin using colon-specific nanoparticles co-modified with amphiphilic chitosan derivatives and cell-penetrating peptides.
F. Guo (2019)
Chitosan and its derivatives in mucosal drug and vaccine delivery.
I. M. van der Lubben (2001)
Expression of human insulin gene wrapped with chitosan nanoparticles in NIH3T3 cells and diabetic rats
Li Niu (2008)
Type 2 diabetes as a lipid disorder.
M. Taskinen (2005)
Self-assembled lecithin/chitosan nanoparticles for oral insulin delivery: preparation and functional evaluation
Liyao Liu (2016)
A review on chitosan and its nanocomposites in drug delivery.
A. Ali (2018)
Probing insulin's secondary structure after entrapment into alginate/chitosan nanoparticles.
B. Sarmento (2007)
Towards the nasal delivery of insulin.
H. Nazar (2012)
Complex Coacervates between a Lactose-Modified Chitosan and Hyaluronic Acid as Radical-Scavenging Drug Carriers.
Federica Vecchies (2018)
Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity.
M. Márquez (2016)
Insulin analogs for the treatment of diabetes mellitus: therapeutic applications of protein engineering
Daniel F. Berenson (2011)
Chitosan and its use in design of insulin delivery system.
T. Wong (2009)
Nasal and rectal delivery of insulin with chitosan and N-trimethyl chitosan chloride
L. D. du Plessis (2010)
Application of chitin and chitosan derivatives in the pharmaceutical field.
Y. Kato (2003)
Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement.
N. G. Schipper (1999)
Degradability of chitosan micro/nanoparticles for pulmonary drug delivery
N. Islam (2019)
The regulatory effects of fish oil and chitosan on hepatic lipogenic signals in high-fat diet-induced obese rats.
C. Chiu (2017)
Estrone-modified pH-sensitive glycol chitosan nanoparticles for drug delivery in breast cancer.
H. Yang (2018)
The effect of chronic insulin delivery via the intraperitoneal versus the subcutaneous route on hepatic triglyceride secretion rate in streptozotocin diabetic rats.
T. M. Mason (2002)
Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)
P. Artursson (2004)
Chitosan reduces gluconeogenesis and increases glucose uptake in skeletal muscle in streptozotocin-induced diabetic rats.
S. Liu (2010)
Chitosan microspheres as a potential carrier for drugs.
V. Sinha (2004)
New ways of insulin delivery
L. Heinemann (2010)
Antidiabetic effects of chitosan oligosaccharides in neonatal streptozotocin-induced noninsulin-dependent diabetes mellitus in rats.
Hyean-Woo Lee (2003)
Diabetic Dyslipidemia: Causes and Consequences
I. Goldberg (2001)
Protein Instability in Poly(Lactic-co-Glycolic Acid) Microparticles
M. van de Weert (2004)
Antidiabetic action of low molecular weight chitosan in genetically obese diabetic KK-Ay mice.
K. Hayashi (2002)
Novel technique of insulin loading into porous carriers for oral delivery☆
Sarah Y. Eilleia (2018)
Anti-Obesity Effect of Chitosan Oligosaccharide Capsules (COSCs) in Obese Rats by Ameliorating Leptin Resistance and Adipogenesis
H. Pan (2018)
Chitosan reduces plasma adipocytokines and lipid accumulation in liver and adipose tissues and ameliorates insulin resistance in diabetic rats.
Yu-Lin Hsieh (2012)
Chitosan nanoparticles in drug therapy of infectious and inflammatory diseases
P. Rajitha (2016)
Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies.
Shaoyun Yu (2004)
Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review.
M. George (2006)
Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis.
S. Pilkis (1992)
New insights into the pathophysiology of dyslipidemia in type 2 diabetes.
M. Taskinen (2015)
Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo.
Yan Pan (2002)
Molecular Weight Dependent Glucose Lowering Effect of Low Molecular Weight Chitosan Oligosaccharide (GO2KA1) on Postprandial Blood Glucose Level in SD Rats Model
S. Jo (2013)
Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state.
S. Haffner (2000)
Chitosan as a nasal delivery system: evaluation of insulin absorption enhancement and effect on nasal membrane integrity using rat models
T. Aspden (1996)
Antidiabetic Activity of Differently Regioselective Chitosan Sulfates in Alloxan-Induced Diabetic Rats
R. Xing (2015)
In vivo dual-delivery of glucagon like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP4) inhibitor through composites prepared by microfluidics for diabetes therapy
F. Araújo (2016)
Acyl-coenzyme A:cholesterol acyltransferases.
T. Chang (2009)
Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis
Roman Maslennikov (2018)
Controlled delivery of basal level of insulin from chitosan-zinc-insulin-complex-loaded thermosensitive copolymer.
Mayura Oak (2012)
Chitosan and chitosan derivatives in drug delivery and tissue engineering
R. Riva (2011)
Glucagon-Like Peptide 1 Induces Pancreatic β-Cell Proliferation Via Transactivation of the Epidermal Growth Factor Receptor
J. Buteau (2003)
Glucagon‐like peptide 1‐potentiated insulin secretion and proliferation of pancreatic β‐cells GLP‐1促进胰岛素分泌和胰岛β细胞增殖的机制
Xiaosong Ma (2014)
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies.
N. Sarwar (2010)
Combination therapy via oral co-administration of insulin- and exendin-4-loaded nanoparticles to treat type 2 diabetic rats undergoing OGTT.
Er-Yuan Chuang (2013)
Long-Term Feeding of Chitosan Ameliorates Glucose and Lipid Metabolism in a High-Fructose-Diet-Impaired Rat Model of Glucose Tolerance
S. Liu (2015)
The prevalence of dyslipidemia and associated factors in children and adolescents with type 1 diabetes
Tuba Bulut (2017)
A critical review of the toxicology of glutaraldehyde.
R. O. Beauchamp (1992)
Structural basis for physiological regulation of paracellular pathways in intestinal epithelia
J. Madara (2005)
Effect of chitosan on epithelial permeability and structure.
V. Dodane (1999)
Analysis of toxicity and biocompatibility of chitosan derivatives with different physico-chemical properties
E. Svirshchevskaya (2016)
A comparative study on hypoglycemic and hypocholesterolemic effects of high and low molecular weight chitosan in streptozotocin-induced diabetic rats.
Hsien-Tsung Yao (2008)
Vitamin B12 functionalized layer by layer calcium phosphate nanoparticles: A mucoadhesive and pH responsive carrier for improved oral delivery of insulin.
A. Verma (2016)
Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
Lichen Yin (2009)
Chitosan Coated Cotton Fiber: Physical and Antimicrobial Properties for Apparel Use
M. A. Rahman Bhuiyan (2016)
Nasal route and drug delivery systems
S. Türker (2004)
Chitosan Modification and Pharmaceutical/Biomedical Applications
J. Zhang (2010)
Preparation and characterization of insulin nanoparticles using chitosan and Arabic gum with ionic gelation method.
M. R. Avadi (2010)
Chitosan as a Novel Nasal Delivery System for Peptide Drugs
L. Illum (2004)
Supplementation of chitosan alleviates high-fat diet-enhanced lipogenesis in rats via adenosine monophosphate (AMP)-activated protein kinase activation and inhibition of lipogenesis-associated genes.
C. Chiu (2015)
Nanosphere based oral insulin delivery.
G. Carino (2000)
Type 2 diabetes mellitus
R. DeFronzo (2015)
Liver-targeted delivery of insulin-loaded nanoparticles via enterohepatic circulation of bile acids
Zhe Zhang (2018)
A thermosensitive hydrogel based on quaternized chitosan and poly(ethylene glycol) for nasal drug delivery system.
J. Wu (2007)
Health economics and compliance of vials/syringes versus pen devices: a review of the evidence.
C. Asche (2010)
This paper is referenced by
Alginate: From Food Industry to Biomedical Applications and Management of Metabolic Disorders
Roxana Gheorghita Puscaselu (2020)
Alginate Calcium Microbeads Containing Chitosan Nanoparticles for Controlled Insulin Release
J. Li (2020)